Written Verb Naming Improves After tDCS Over the Left IFG in Primary Progressive Aphasia

by Amberlynn S. Fenner, Kimberly T. Webster, Kimberly T. Webster, Bronte N. Ficek, Constantine E. Frangakis, Constantine E. Frangakis, Constantine E. Frangakis, Kyrana Tsapkini, Kyrana Tsapkini
Published 2019-06-01

Abstract #152: Sleep as a Predictor of tDCS Therapy Outcomes

by Kyrana Tsapkini, Haley Wendt, Bronte N. Ficek, Kimberly T. Webster, Constantine Frangakis, Adam P. Spira
Published 2019-03-01

Abstract #113: Individualized Modeling for Subjects with Primary Progressive Aphasia

by Gozde Unal, Bronte N. Ficek, Kimberly T. Webster, Syed Shahabuddin, Dennis Q. Truong, Marom Bikson, Kyrana Tsapkini
Published 2019-03-01

“The effect of tDCS on functional connectivity in primary progressive aphasia” NeuroImage: Clinical, volume 19 (2018), pages 703–715

by Bronte N. Ficek, Zeyi Wang, Yi Zhao, Kimberly T. Webster, John E. Desmond, Argye E. Hillis, Constantine Frangakis, Andreia Vasconcellos Faria, Brian Caffo, Kyrana Tsapkini
Published 2019-01-01

The effect of tDCS on functional connectivity in primary progressive aphasia

by Bronte N. Ficek, Zeyi Wang, Yi Zhao, Kimberly T. Webster, John E. Desmond, Argye E. Hillis, Constantine Frangakis, Andreia Vasconcellos Faria, Brian Caffo, Kyrana Tsapkini
Published 2018-01-01

Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria.

by John Devin Peipert, Austin G Kulasekararaj, Anna Gaya, Saskia M C Langemeijer, Susan Yount, F Ataulfo Gonzalez-Fernandez, Emilio Ojeda Gutierrez, Christa Martens, Amy Sparling, Kimberly A Webster, David Cella, Ioannis Tomazos, Masayo Ogawa, Caroline I Piatek, Richard Wells, Flore Sicre de Fontbrune, Alexander Röth, Lindsay Mitchell, Anita Hill, Karen Kaiser
Published 2020-01-01